A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Clinical Trial ID NCT02261220

PubWeight™ 8.18^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02261220

Top papers